These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32271412)

  • 1. HOXA10 promotes the development of bladder cancer through regulating FOSL1.
    Cui YP; Xie M; Pan WX; Zhang ZY; Li WF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2945-2954. PubMed ID: 32271412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Feng F; Chen AP; Wang XL; Wu GL
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIIP inhibits malignant progression of hepatocellular carcinoma through regulating AKT.
    Fang J; Chen YL; Yao HB; Peng SS; Yang P; Ding ZY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2335-2346. PubMed ID: 32196585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.
    Dai L; Chai CM; Shen TY; Tian Y; Shang ZQ; Niu YJ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6858-6867. PubMed ID: 31486485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETV4 promotes the progression of gastric cancer through regulating KDM5D.
    Cai LS; Chen QX; Fang SY; Lian MQ; Lian MJ; Cai MZ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2442-2451. PubMed ID: 32196595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-9501 inhibits breast cancer proliferation and metastasis through regulating Wnt/β-catenin pathway.
    Que LM; Yang XR; Zhang YC; Zhong H
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4337-4347. PubMed ID: 32373971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer.
    Song C; Han Y; Luo H; Qin Z; Chen Z; Liu Y; Lu S; Sun H; Zhou C
    Cancer Med; 2019 Sep; 8(12):5651-5661. PubMed ID: 31364281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFAIP8 regulates cisplatin resistance through TAF-Iα and promotes malignant progression of esophageal cancer.
    Zhang DL; Yang N
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4775-4784. PubMed ID: 32432789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway.
    Wang YL; Li Y; Ma YG; Wu WY
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9489-9498. PubMed ID: 31773701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
    Tan SF; Ni JX; Xiong H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
    Zhang L; Xia HB; Zhao CY; Shi L; Ren XL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):86-96. PubMed ID: 31957821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer.
    Fan LY; Shi KY; Xu D; Ren LP; Yang P; Zhang L; Wang F; Shao GL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10842-10850. PubMed ID: 31858553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
    Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway.
    Wu JZ; Jiang N; Lin JM; Liu X
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2977-2985. PubMed ID: 32271415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
    Zhang Y; Yuan Z; Jiang Y; Shen R; Gu M; Xu W; Gu X
    Med Sci Monit; 2020 Jan; 26():e919460. PubMed ID: 31927557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA TRERNA1 promotes malignant progression of NSCLC through targeting FOXL1.
    Luo DB; Lv HB; Sun XH; Wang Y; Chu JH; Salai AL
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1233-1242. PubMed ID: 32096153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3.
    Zhu QL; Zhan DM; Chong YK; Ding L; Yang YG
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8806-8812. PubMed ID: 31696467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.